The Role of Toll-like Receptors in Regulating the Immune Response against Respiratory Syncytial Virus

被引:51
作者
Klouwenberg, Peter Klein [1 ]
Tan, Lydia [1 ]
Werkman, Wendy [1 ]
van Bleek, Grada M. [2 ]
Coenjaerts, Frank E. J. [1 ]
机构
[1] Univ Med Ctr Utrecht, Dept Med Microbiol, NL-3584 CX Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Dept Pediat, NL-3584 CX Utrecht, Netherlands
关键词
RSV; respiratory syncytial virus; TLR; Toll-like receptor; immunopathogenesis; DOUBLE-STRANDED-RNA; PATTERN-RECOGNITION RECEPTORS; NF-KAPPA-B; AIRWAY EPITHELIAL-CELLS; INNATE IMMUNITY; SIGNALING PATHWAYS; TLR4; POLYMORPHISMS; FUSION PROTEIN; TRACT DISEASE; BALB/C MICE;
D O I
10.1615/CritRevImmunol.v29.i6.40
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Toll-like receptors (TLRs) play a distinct role in battling respiratory syncytial virus (RSV) infections. However, due to a lack of representative animal models and several early controversies, the field is unclear. In this systematic review, we have elucidated conflicting results and outlined important factors that might affect study outcomes. We reviewed studies that used different doses/viral strains, performed virus propagation in different cell lines, or used different mice strains. The following firm conclusions can be drawn: multiple TLRs activate innate immunity upon RSV infection; TLR4 can influence TLR2 expression, suggesting that optimal induction of multiple signaling pathways is required to elicit protective, rather than deleterious innate immune responses following infection; in mice, TLR4, TLR2/-6, and TLR7 have immune-stimulating properties, while TLR3 activation occurs later and appears to downregulate immune responses; in humans, polymorphism studies have demonstrated an important role for TLR4-signaling; and activation of TLR-signaling leads to antiviral cytokine production, such as TNF-alpha and IFNs. Viral factors may block these pathways, thereby contributing to immune evasion and RSV survival. A better understanding of the complex interplay between TLRs and severe RSV infections might lead to efficient prophylactic and therapeutic treatments, as well as the development of adequate vaccines combined with TLR adjuvants.
引用
收藏
页码:531 / 550
页数:20
相关论文
共 145 条
[1]   Pathogen recognition and innate immunity [J].
Akira, S ;
Uematsu, S ;
Takeuchi, O .
CELL, 2006, 124 (04) :783-801
[2]   Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 [J].
Alexopoulou, L ;
Holt, AC ;
Medzhitov, R ;
Flavell, RA .
NATURE, 2001, 413 (6857) :732-738
[3]   Genetic Diversity of the Host and Severe Respiratory Syncytial Virus-induced Lower Respiratory Tract Infection [J].
Amanatidou, Virginia ;
Apostolakis, Stavros ;
Spandidos, Demetrios A. .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2009, 28 (02) :135-140
[4]   The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-β promoter [J].
Andrejeva, J ;
Childs, KS ;
Young, DF ;
Carlos, TS ;
Stock, N ;
Goodbourn, S ;
Randall, RE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (49) :17264-17269
[5]   TLR4 mutations are associated with endotoxin hyporesponsiveness in humans [J].
Arbour, NC ;
Lorenz, E ;
Schutte, BC ;
Zabner, J ;
Kline, JN ;
Jones, M ;
Frees, K ;
Watt, JL ;
Schwartz, DA .
NATURE GENETICS, 2000, 25 (02) :187-+
[6]   Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children [J].
Awomoyi, Agnes A. ;
Rallabhandi, Prasad ;
Pollin, Toni I. ;
Lorenz, Eva ;
Sztein, Marcelo B. ;
Boukhvalova, Marina S. ;
Hemming, Val G. ;
Blanco, Jorge C. G. ;
Vogel, Stefanie N. .
JOURNAL OF IMMUNOLOGY, 2007, 179 (05) :3171-3177
[7]   Coordinating TLR-activated signaling pathways in cells of the immune system [J].
Banerjee, Ashish ;
Gerondakis, Steve .
IMMUNOLOGY AND CELL BIOLOGY, 2007, 85 (06) :420-424
[8]   Respiratory syncytial virus(RSV)-induced allergy may be controlled by IL-4 and CX3C fractalkine antagonists and CpG ODN as adjuvant: hypothesis and implications for treatment [J].
Becker, Yechiel .
VIRUS GENES, 2006, 33 (02) :253-264
[9]   Immunopathogenesis of respiratory syncytial virus bronchiolitis [J].
Bennett, Berkeley L. ;
Garofalo, Roberto P. ;
Cron, Stanley G. ;
Hosakote, Yashoda M. ;
Atmar, Robert L. ;
Macias, Charles G. ;
Piedra, Pedro A. .
JOURNAL OF INFECTIOUS DISEASES, 2007, 195 (10) :1532-1540
[10]   The TLR4 agonist, monophosphoryl lipid A, attenuates the cytokine storm associated with respiratory syncytial virus vaccine-enhanced disease [J].
Boukhvalova, Marina S. ;
Prince, Gregory A. ;
Soroush, Layla ;
Harrigan, Dolores C. ;
Vogel, Stefanie N. ;
Blanco, Jorge C. G. .
VACCINE, 2006, 24 (23) :5027-5035